← Research & Industry News
External source
Light-controlled nanoparticles enable on-demand drug delivery for chronic wounds
Researchers develop light-responsive silica nanoparticles that release antibacterial drugs on demand, offering a potential way to improve chronic wound treatment.
- Published by
- Nanowerk
- Evidence type
- Laboratory
Researchers develop light-responsive silica nanoparticles that release antibacterial drugs on demand, offering a potential way to improve chronic wound treatment.
This item was selected automatically by our daily literature and news monitor because it matches the topics we follow. Read the full story at Nanowerk.
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.
ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.
